abrine has been researched along with Liver Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H; Han, S; He, J; Liang, X; Xiao, J; Yang, S; Yao, C; Yuan, R | 1 |
1 other study(ies) available for abrine and Liver Neoplasms
| Article | Year |
|---|---|
Abrine, an IDO1 inhibitor, suppresses the immune escape and enhances the immunotherapy of anti-PD-1 antibody in hepatocellular carcinoma.
Topics: Animals; B7-H1 Antigen; Carcinoma, Hepatocellular; CD47 Antigen; CD8-Positive T-Lymphocytes; Humans; Immunotherapy; Indole Alkaloids; Interferon-gamma; Liver Neoplasms; Molecular Docking Simulation; Tryptophan | 2023 |